Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Rugarli

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Opinion in Neurology|June 4, 2025
MRI protocols and sequences for amyloid-related imaging abnormalities monitoring in Alzheimer's disease patients treated with monoclonal antibodiesFederica Agosta, Giordano Cecchetti, Edoardo G Spinelli, et al.
The Lancet Regional Health. Europe|February 24, 2026
Anti-amyloid therapies and the transformation of Alzheimer's care pathways: early lessons from the frontlineMassimo Filippi, Giordano Cecchetti, Edoardo G Spinelli, et al.
Alzheimer'S Research & Therapy|May 22, 2026
Plasma ApoE proteotyping for ApoE ε4 stratification in the anti-amyloid therapies eraFederico Coraglia, Giordano Cecchetti, Giulia Rugarli, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersGiulia Rugarli, Giordano Cecchetti, Roberto Santangelo, et al.
The Lancet Regional Health. Europe|July 2, 2026
From Target Engagement to Treatment Governance: The Evolving Role of Amyloid PET in Anti-Amyloid TherapyMassimo Filippi, Giordano Cecchetti, Alma Ghirelli, et al.
Journal of Neurology|August 28, 2025
Fragile X-associated tremor/ataxia syndrome: a case report with atypical spinal cord atrophy and altered somatosensory evoked potentialsGiulia Rugarli, Giorgio Maria Agazzi, Roberto Santangelo, et al.
Brain Communications|April 26, 2024
Caudate functional networks influence brain structural changes with agingSilvia Basaia, Matteo Zavarella, Giulia Rugarli, et al.
Journal of Neurology|August 22, 2024
Diagnostic accuracy of automated Lumipulse plasma pTau-217 in Alzheimer's disease: a real-world studyGiordano Cecchetti, Federica Agosta, Giulia Rugarli, et al.
European Journal of Neurology|May 25, 2023
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experienceSimone Guerrieri, Chiara Bucca, Agostino Nozzolillo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 18, 2026
Serial amyloid PET as a decision tool for switching anti-amyloid therapy in Alzheimer's diseaseMassimo Filippi, Alma Ghirelli, Giordano Cecchetti, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Opinion in Neurology|June 4, 2025
MRI protocols and sequences for amyloid-related imaging abnormalities monitoring in Alzheimer's disease patients treated with monoclonal antibodiesFederica Agosta, Giordano Cecchetti, Edoardo G Spinelli, et al.
The Lancet Regional Health. Europe|February 24, 2026
Anti-amyloid therapies and the transformation of Alzheimer's care pathways: early lessons from the frontlineMassimo Filippi, Giordano Cecchetti, Edoardo G Spinelli, et al.
Alzheimer'S Research & Therapy|May 22, 2026
Plasma ApoE proteotyping for ApoE ε4 stratification in the anti-amyloid therapies eraFederico Coraglia, Giordano Cecchetti, Giulia Rugarli, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersGiulia Rugarli, Giordano Cecchetti, Roberto Santangelo, et al.
The Lancet Regional Health. Europe|July 2, 2026
From Target Engagement to Treatment Governance: The Evolving Role of Amyloid PET in Anti-Amyloid TherapyMassimo Filippi, Giordano Cecchetti, Alma Ghirelli, et al.
Journal of Neurology|August 28, 2025
Fragile X-associated tremor/ataxia syndrome: a case report with atypical spinal cord atrophy and altered somatosensory evoked potentialsGiulia Rugarli, Giorgio Maria Agazzi, Roberto Santangelo, et al.
Brain Communications|April 26, 2024
Caudate functional networks influence brain structural changes with agingSilvia Basaia, Matteo Zavarella, Giulia Rugarli, et al.
Journal of Neurology|August 22, 2024
Diagnostic accuracy of automated Lumipulse plasma pTau-217 in Alzheimer's disease: a real-world studyGiordano Cecchetti, Federica Agosta, Giulia Rugarli, et al.
European Journal of Neurology|May 25, 2023
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experienceSimone Guerrieri, Chiara Bucca, Agostino Nozzolillo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 18, 2026
Serial amyloid PET as a decision tool for switching anti-amyloid therapy in Alzheimer's diseaseMassimo Filippi, Alma Ghirelli, Giordano Cecchetti, et al.
Pageof 2